Bob Baltera

Bob Baltera is an accomplished executive in the biotechnology sector, currently serving as a Board Member for Imago BioSciences, Inc. and Inipharm, since April 2020 and July 2019, respectively. Baltera has held the position of CEO at Cirius Therapeutics since April 2017, following prior leadership roles as CEO at Hawkeye Therapeutics and Laguna Pharmaceuticals between January 2016 and December 2015, and at Amira Pharmaceuticals from July 2007 to September 2011. Additionally, Baltera served on the Board of Directors for Organovo Holdings, Inc. from September 2010 to September 2019. Prior to these roles, Baltera was Vice President at Amgen for 17 years, from November 1990 to July 2007. Educationally, Baltera earned a Master's degree in Genetics from Penn State University and a Bachelor's degree in Microbiology from the same institution, in addition to completing a program at the UCLA Anderson School of Management.